• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ: AYTU )

1.380 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,972
Open 1.440
Bid (Size) 1.350 (5)
Ask (Size) 1.450 (2)
Prev. Close 1.380
Today's Range 1.350 - 1.440
52wk Range 1.300 - 3.450
Shares Outstanding 5,567,490
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aytu BioPharma Disclosure Notification
December 03, 2024
Via ACCESSWIRE
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)
November 22, 2024
Via ACCESSWIRE

Performance

YTD
-52.25%
-52.25%
1 Month
-8.50%
-8.50%
3 Month
-42.02%
-42.02%
6 Month
-53.22%
-53.22%
1 Year
-52.58%
-52.58%

More News

Read More
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
November 13, 2024
Via ACCESSWIRE
Earnings Scheduled For November 13, 2024
November 13, 2024
Via Benzinga
Aytu BioPharma's Earnings: A Preview
November 12, 2024
Via Benzinga
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024
November 06, 2024
Via ACCESSWIRE
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit
October 14, 2024
Via ACCESSWIRE
Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results
September 26, 2024
Via ACCESSWIRE
Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations
August 06, 2024
Via ACCESSWIRE
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
June 18, 2024
Via ACCESSWIRE
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
October 01, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 27, 2024
Via Benzinga
Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024
September 16, 2024
Via ACCESSWIRE
Sidoti Events, LLC's Virtual August Micro-Cap Conference
August 13, 2024
Via ACCESSWIRE
Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024
August 08, 2024
Via ACCESSWIRE
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
April 03, 2024
Via ACCESSWIRE
Earnings Scheduled For February 14, 2024
February 14, 2024
Via Benzinga
Earnings Preview: Aytu BioPharma
February 13, 2024
Via Benzinga
Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024
May 29, 2024
Via Newsfile
Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
May 23, 2024
Via ACCESSWIRE
AYTU Stock Earnings: Aytu BioPharma Beats EPS, Beats Revenue for Q3 2024
May 15, 2024
Via InvestorPlace
Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
May 08, 2024
Via ACCESSWIRE
Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
February 14, 2024
Via ACCESSWIRE
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
February 07, 2024
Via ACCESSWIRE
Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
January 23, 2024
Via ACCESSWIRE
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap